Vice President and Executive Director Xie Xin increased his holdings of SINO BIOPHARM (01177) by 1 million shares, with an average price of approximately HK $6.41 per share.
According to the latest data from the Hong Kong Stock Exchange, Vice President and Executive Director, Xie Xin, increased his stake in China Biopharmaceuticals (01177) on December 24 by purchasing 1 million shares at a price of 6.4068 Hong Kong dollars per share, for a total amount of 6.4068 million Hong Kong dollars.
The latest information from the Hong Kong Stock Exchange shows that on December 24, Vice President and Executive Director Xie Xin increased his holding of 1 million shares of SINO BIOPHARM (01177) at a price of 6.4068 Hong Kong dollars per share, with a total amount of 6.4068 million Hong Kong dollars. The latest number of shares held after the increase is approximately 361 million shares, with the latest shareholding ratio being 1.92%.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
